Open Access Open Access  Restricted Access Subscription Access

An Insight into Drugs Used in Eye Disorders

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


This review article provides a little information about commonly used drugs in the treatment of eye disorders. Glaucoma treatment decreases intra ocular pressure (IOP) to stop optic nerve damage. Common types are prostaglandin analogs (eg. Latonoprost), beta_ blockers (eh. Timolol), alpha agonist (eh. Apraclonidine) and carbonic anhydrase inhibitors (eg. Dorzolamide). They can exhibit side effects such as redness, blurred bvision or stinging. PG analogs namely latanoprost and bimatoprost decrease IOP by enhancing the outflow of aqueous humor. Beta blockers such as tomolol and butaxolol decrease the production of aqueous humor by decreasing IOP. An administration of corticosteroids by topical route or systemic route decrease inflammation. Side effects include increased IOP and cataract formation. Dexamethasone and prednisolone are primarily used for treating ocular conditions. Prednisone is used to treat uveitis and allergic conjunctivitis. This srug decrease inflammation and alleviate symptoms. Antibiotics are used in bacterial conjunctivitis. Finally it is concluded that as the research and technology continue to progress, the future results in more targeted and effective Drugs especially in the field of ophthalmology.


Full Text:

PDF

References


Shekhawat, N. S., Shtein, R. M., Blachley, T. S., & Stein, J. D. (2017). Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology, 124(8), 1099-1107.

Smith, A. F., & Waycaster, C. (2009). Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC ophthalmology, 9(1), 1-11.

Alfonso, S. A., Fawley, J. D., & Lu, X. A. (2015). Conjunctivitis. Primary Care: Clinics in Office Practice, 42(3), 325-345.

De Laet, C., Dionisi-Vici, C., Leonard, J. V., McKiernan, P., Mitchell, G., Monti, L., ... & Spiekerkötter, U. (2013). Recommendations for the management of tyrosinaemia type 1. Orphanet journal of rare diseases, 8, 1-9.

Sati, A., Sangwan, V. S., & Basu, S. (2013). Porphyria: varied ocular manifestations and management. Case Reports, 2013, bcr2013009496.

Azari, A. A., & Barney, N. P. (2013). Conjunctivitis: a systematic review of diagnosis and treatment. Jama, 310(16), 1721-1730.

Høvding, G. (2008). Acute bacterial conjunctivitis. Acta ophthalmologica, 86(1), 5-17.

Shields, T., & Sloane, P. D. (1991). A comparison of eye problems in primary care and ophthalmology practices. Family medicine, 23(7), 544-546.

Ramirez, D. A., Porco, T. C., Lietman, T. M., & Keenan, J. D. (2017). Epidemiology of conjunctivitis in US emergency departments. JAMA ophthalmology, 135(10), 1119-1121.

Wong, A. H., Barg, S. S., & Leung, A. K. (2009). Seasonal and perennial allergic conjunctivitis. Recent Patents on Inflammation & Allergy Drug Discovery, 3(2), 118-127.


Refbacks

  • There are currently no refbacks.